Fact CheckerSign in

NCT06709261Completed

Safety and Performance of the OTTAVA Robotic System

EDS-2022-01: Safety and Performance of the OTTAVA™ Robotic System: A Prospective, Multi-Center Evaluation (FORTE)

Source: ClinicalTrials.gov · Last updated 28 Sept 2026

Brief summary (registry, in English)

This study assesses safety and performance of the OTTAVA Robotic System, through 30 days postoperative, in subjects undergoing robotic-assisted Roux-en-Y Gastric Bypass (RYGB) procedure.

Status (registry)
Completed
Study type
Interventional
Enrollment
32 (actual)
First submitted
21 Nov 2024
Start date
5 Feb 2025
Primary completion date
20 Oct 2025
Lead sponsor
Auris Health, Inc.
Diseases
Obesity
NCT number
NCT06709261

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From 5 Feb 2025 to the primary completion date, 20 Oct 2025
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Criteria for Inclusion:
  • Willing and able to provide informed consent;
  • Scheduled for an elective primary RYGB surgical procedure;
  • American Society of Anesthesiologists classification ≤ ASA III;
  • Body habitus such that the procedure can be safely completed with OTTAVA Robotic System;
  • Body weight \<500 lb (227 kg);
  • Patient presenting with class 2 or 3 obesity (BMI ≥ 35), regardless of comorbidities, or obesity with health risk satisfying 2022 ASMBS/IFSO indications for bariatric surgery; and
  • A minimum of 21 years of age (at time of consent).
    • Criteria for Exclusion:
  • Surgeon determination that there is a medical condition, that makes surgery too risky, including intraoperative finding;
  • Concomitant surgical procedure including cholecystectomy (hiatal hernia repair up to 5 cm and adhesiolysis allowed);
  • Upper abdominal surgery within two years prior to enrollment (prior laparoscopic cholecystectomy allowed);
  • Evidence of hiatal hernia \>5 cm (preoperative/intraoperative);
  • Enrolled in another investigational study that may confound the results of this study;
  • Emergency surgery;
  • Active pregnancy; or
  • Subject from a vulnerable population, including anyone unable to adequately provide informed consent.

Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UT Health Houston and Memorial Hermann TMC
Coordinator of this site? Confirm its status
BellaireUnited StatesUnknown status
Duke Regional Hospital
Coordinator of this site? Confirm its status
DurhamUnited StatesUnknown status
IU Health North Hospital
Coordinator of this site? Confirm its status
IndianapolisUnited StatesUnknown status
NYU Long Island
Coordinator of this site? Confirm its status
MineolaUnited StatesUnknown status
Orlando Health
Coordinator of this site? Confirm its status
OrlandoUnited StatesUnknown status
University of South Florida (Tampa General Hospital)
Coordinator of this site? Confirm its status
TampaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.